Fundraising Fox
🦊/Companies
Sign in

SEngine Precision Medicine

Seattle, US · Founded 2015 · Delaware corporation · 4 known investors

Find your way into SEngine Precision Medicine

305 people in our graph share verified history with the SEngine Precision Medicine team — schools, employers, funds. One of them is your warm intro.

Adrianna Maunlockedknows Carla Grandori · together at Massachusetts Institute of Technology (overlapped)
×7knows the team · via Massachusetts Institute of Technology
×2knows the team · via Tempus AI
knows the team · via Fred Hutch
knows the team · via The Rockefeller University
Biotech

Founders & leadership

SEngine Precision Medicine was founded in 2015 by Christopher Kemp and Carla Grandori.

CK
Christopher KempCo-founder
CGCarla Grandori
Carla GrandoriinCo-founder · Chief Executive Officer2015–2023She brings over 30 years of cancer research experience, including roles as VP of clinical modeling and functional genomics at Tempus AI and research positions at Fred Hutchinson Cancer Research Center and the University of Washington.
EB
Elliott BurklandNamed on SEC filing
TNTom Neary
Tom NearyinChief Financial Officer2019–2022Executive Officer at Spaceflight Industries
LH
Lee HartwellNamed on SEC filing
JF
Jesse FerrerNamed on SEC filing
UM
Ulrich MuellerNamed on SEC filing

Investors · 4

ALETHEA FULCRUMreported · 2 sourcesRancho Santa Fe

Also in the syndicate · 3

Bangarang GroupVincere Capital Biotech LLCWashington Research Foundationlead

Funding

SEC filings, press & company announcements

$9.2M disclosed across 2 of 3 rounds · 2018–2023

▶$600KraisedMar 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher KempExecutive Officer, Promoter
  • Pablo PrichardDirector
  • Tony HsuExecutive Officer
  • Elliott BurklandDirector
  • Carla GrandoriExecutive Officer, Director, Promoter
Offering amount
$3.6M
Amount sold
$600K
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.6MraisedOct 2019 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Elliott BurklandDirector
  • Tom NearyExecutive Officer
  • Christopher KempExecutive Officer, Promoter
  • Lee HartwellDirector
  • Jesse FerrerDirector
  • Ulrich MuellerExecutive Officer
  • Carla GrandoriExecutive Officer, Director, Promoter
Offering amount
$13.6M
Amount sold
$8.6M
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

SEngine Precision Medicine closes Series A bringing total financing to $19M enabling continued advancement of personalized cancer treatments - BioSpacebiospace.com · Jul 2022SEngine Precision Medicine and Oncodesign Announce a Collaboration Agreement - Oncodesign Precision Medicineoncodesign.com · Feb 2022Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient's tumors – GeekWiregeekwire.com · Oct 2019SEngine Precision Medicine Raises $5.1 Million Series A to Advance Personalized Oncology Drug Discovery Platformglobenewswire.com · Oct 2019SEngine Precision Medicine Raises $5.1M in Series A Funding - FinSMEsfinsmes.com · Oct 2019SEngine Precision Medicine raises $3M, adds former Fred Hutch president to board – GeekWiregeekwire.com · Oct 2018

Frequently asked questions

Who founded SEngine Precision Medicine?
SEngine Precision Medicine was founded by Christopher Kemp, Carla Grandori in 2015.
Who are SEngine Precision Medicine's investors?
SEngine Precision Medicine's investors include ALETHEA FULCRUM.
How much funding has SEngine Precision Medicine raised?
SEngine Precision Medicine has disclosed $9.2M raised across 2 of its 3 known rounds.
Where is SEngine Precision Medicine headquartered?
SEngine Precision Medicine is headquartered in Seattle, US.